Pharmaceutical Manufacturing Facility

This project is being executed in three phases: preconstruction, early works, and main works. It covers an area of nearly 3,000 m² within an operational pharmaceutical manufacturing facility in Broadmeadows.

Key components of the project include the construction of new GMP change amenities on Level 3, the installation of specialised clean water and gas systems, a bulk process system featuring Clean-in-Place (CIP) and temperature control skids, and the addition of new fill-finish equipment, including a new aseptic filling line.

The project began with a successful Early Contractor Involvement (ECI) phase, during which Built Environs provided services such as cost planning, program development, design advice, buildability assessments, and site planning and logistics.

Due to the operational nature of the facility, several brownfield zones were carefully planned and coordinated with the client to minimize disruption to critical operations. Key activities and commissioning tasks were scheduled around four main shutdown periods, necessitating detailed programming for continuous 24/7 operations over several weeks.

Specific facility shutdown periods were identified as critical points for disruptive work, tie-ins for new installations, and modifications to existing facilities. Shutdown work included craning and rigging structural steel members, large process vessels, and fill-finish equipment through several roof and wall access openings.

The cleanroom construction involved Askin panel wall and ceiling systems, with floors finished with a durable, multi-layer epoxy coating. Building services including mechanical, fire, electrical, process waste, clean utilities, and control systems, were all installed and completed while maintaining operations in live cleanroom areas. Final tie-ins, commissioning, and validation were conducted during the designated shutdown periods.